ESSA Pharma EPIX

$ 1.6 0.0%

Annual report 2024
added 12-17-2024

ESSA Pharma Balance Sheet 2011-2024 | EPIX

Annual Balance Sheet ESSA Pharma

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-56.9 M	-137 M	-56.3 M	-49.6 M	-8.51 M	4 M	-8.99 M	-1.57 M	-3.7 M	-	-	-
Long Term Debt	205 K	-	76.4 K	210 K	-	-	3.5 M	5.93 M	-	-	-	-	-	-
Long Term Debt Current	124 K	80.3 K	134 K	121 K	59.1 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	127 K	18.2 K	3.52 M	6.1 M	-	-	-	-	-	-
Total Current Liabilities	3.3 M	3.5 M	2.31 M	3.93 M	1.2 M	-	-	-	-	-	-	-	-	-
Total Liabilities	3.51 M	3.5 M	2.39 M	4.16 M	1.33 M	5.59 M	6.87 M	10.1 M	10.9 M	3.07 M	2.23 M	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-208 M	-179 M	-153 M	-118 M	-81 M	-54.8 M	-44.4 M	-33 M	-28.2 M	-13.1 M	-5.95 M	-	-	-
Total Assets	128 M	149 M	170 M	198 M	80.6 M	54.8 M	16 M	5.61 M	10.4 M	7.49 M	4.2 M	-	-	-
Cash and Cash Equivalents	104 M	33.7 M	57.1 M	138 M	56.3 M	53.3 M	14.8 M	-	-	-	-	-	-	-
Book Value	125 M	146 M	167 M	194 M	79.2 M	49.2 M	9.15 M	-4.5 M	-537 K	4.43 M	1.97 M	-	-	-
Total Shareholders Equity	125 M	146 M	167 M	194 M	79.2 M	49 M	8.94 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet ESSA Pharma

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	230 K	253 K	275 K	-	-	19.8 K	48.3 K	76.4 K	-	145 K	169 K	210 K	220 K	210 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	3.8 M	4.43 M	3.81 M	3.5 M	3.41 M	2.17 M	2.98 M	2.39 M	-	3.89 M	3.95 M	4.16 M	3.83 M	4.16 M	2.07 M	1.33 M	1.33 M	1.33 M	-	5.59 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-202 M	-194 M	-185 M	-179 M	-174 M	-167 M	-160 M	-153 M	-	-138 M	-127 M	-118 M	-109 M	-118 M	-87.5 M	-81 M	-81 M	-81 M	-	-57.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	133 M	138 M	144 M	149 M	154 M	159 M	165 M	170 M	-	183 M	191 M	198 M	204 M	198 M	76.2 M	80.6 M	80.6 M	80.6 M	-	54.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	86 M	91.7 M	35.3 M	33.7 M	38.5 M	44.3 M	51.2 M	57.1 M	67.9 M	86.2 M	121 M	138 M	145 M	138 M	52.5 M	56.3 M	56.3 M	56.3 M	45.9 M	53.3 M	-	-	-	14.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	129 M	133 M	141 M	146 M	150 M	156 M	162 M	167 M	-	179 M	188 M	194 M	200 M	194 M	74.1 M	79.2 M	79.2 M	79.2 M	-	49 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	129 M	133 M	141 M	146 M	150 M	156 M	162 M	167 M	172 M	179 M	188 M	194 M	200 M	188 M	74.1 M	74.1 M	74.1 M	74.1 M	45.8 M	49 M	-	-	-	8.94 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency